Skip to main content
. 2024 Apr 29;15(2):689–709. doi: 10.21037/jgo-24-218

Table 2. Treatment response with targeted agents in IPW-adjusted cohort.

Treatment response pNEN (%) epNEN (%)
Suru Suni + Eve P value Suru Eve P value
Best response <0.001
   PR 21.0 9.9 0.004 6.2 5.6
   SD 70.2 65.7 79.7 58.4
   PD 8.8 24.3 14.1 36.0
ORR 21.0 9.9 0.03 6.2 5.6 0.84
DCR 91.2 75.7 0.004 85.9 64.0 <0.001

IPW, inverse probability weighting; pNEN, pancreatic neuroendocrine neoplasm; epNEN, extrapancreatic neuroendocrine neoplasm; Suru, surufatinib; Suni, sunitinib; Eve, everolimus; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate.